Educational Panel : New Treatments for Diabetes and Obesity: Innovations for Chronic Diseases

feb 12, 2019: 9 a.m. - 10 a.m.
Shubert Complex

BIO%u2019s latest report on highly prevalent chronic diseases shows a slowdown in overall investment for new treatments for diabetes and obesity (available at http://www.bio.org/iareports). However, there remain signs of hope in the early-stage pipeline. This session will detail the drug pipeline, which research approaches are convincing skeptical investors, as well as opportunities for overcoming high-cost clinical trials and reimbursement barriers.

%uFFFD

Moderator: Jason Butler, PhD, Managing Director and Senior Analyst, JMP Securities

Speakers

Jason Butler
Managing Director and ...

Vered Caplan
CEO and President

Steve Daly
US General Manager

Dara Schuster
Chief Executive Officer

David Thomas
Vice President, Indust...